Updated:
THENA Capital
THENA Capital is a London-based venture capital firm focused on early-stage UK medtech companies. The firm provides hands-on commercialization support and...
THENA Capital
THENA Capital is a London-based venture capital firm focused on early-stage UK medtech companies. The firm provides hands-on commercialization support and leverages a deeply embedded industry network to help these businesses expand into the US market. THENA Capital invests in cutting-edge technologies, including digital solutions and fast-track medical devices, that transform patient experiences and empower clinicians. Their portfolio companies address critical needs in areas such as chronic conditions, women's health, oncology, mental health, and care delivery. The firm partners early and moves fast to back bold founders reinventing the future of healthcare. THENA Capital LLP operates as an Appointed Representative of The Fund Incubator Limited (FRN 208716), which is authorized and regulated by the Financial Conduct Authority.
General information
Firm type
Venture Capital
Location
Country
United Kingdom
City
London
Corporate office
London, United Kingdom
Sector focus
Frequently asked questions
What is THENA Capital's investment focus?
THENA Capital focuses on early-stage UK medtech companies offering digital solutions and fast-track medical devices, particularly in chronic conditions, women's health, oncology, mental health, and care delivery.
How does THENA Capital support its portfolio companies?
The firm provides hands-on commercialization support and a deeply embedded industry network to help UK medtech companies expand into the US market.
Where is THENA Capital headquartered and how is it regulated?
THENA Capital is headquartered in London, United Kingdom, and operates as an Appointed Representative of The Fund Incubator Limited, which is authorized and regulated by the Financial Conduct Authority.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: